Biopankkitutkimusten julkaisut

2022

FinnGen-julkaisut

Julkaisut, joissa hyödynnetty FinnGen-aineistoa. (finngen.fi)

2021

Nivelreuman HILMO-diagnoosien validaatiotutkimus

Oili Kaipiainen-Seppänen / KYS Reumatautien poliklinikka

The validity of rheumatoid arthritis diagnoses in Finnish biobanks (pdf)
Paltta J. et al. Scand J Rheumatol (2021)

Pohjois-Savon ihosyöpäohjelma PoSiho, immunomarkkerit melanooman kehittymisen arvioinnissa

Ilkka Harvima / Itä-Suomen yliopisto, Kuopion yliopistollinen sairaala, Ihotautienklinikka

High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types. (doi.org)
Suhonen V. et al. BMC Cancer 21, 1155 (2021).

2020

Biobank and lifestyle data provide opportunities to study development and progression of type 2 diabetes

Arto Mannermaa / Itä-Suomen yliopisto, Kuopion yliopistollinen sairaala

Biobank and lifestyle data provide opportunities to study development and progression of type 2 diabetes (uef.fi)
Piironen A-K, 2020

Hyaluronan metabolism in kidney cancer: Role of tumor microenvironment in epithelial-to-mesenchymal transition and tumor immune recognition

Timo K. Nykopp / Kuopion yliopistollinen sairaala, Kirurgia

Cellular hyaluronan is associated with a poor prognosis in renal cell carcinoma (doi.org)
Jokelainen O. et al. 2020. Urol Oncol. Aug;38(8):686.e11-686.e22. doi: 10.1016/j.urolonc.2020.03.029. Epub 2020 Apr 30.

2019

Biomarkkerit keuhkon karsinoidituumoreissa

Johanna Arola / HUSLAB

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread. (nih.gov)
Vesterinen T. et al. 2019. Jul 12. doi: 10.1530/EC-19⁠-0308

Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research.(nih.gov)
Vesterinen T. et al. 2019. Aug 5. doi: 10.1007/s00428-019⁠-02625-6